ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Oncology Institute Inc

Oncology Institute Inc (TOI)

0.295
0.0125
(4.42%)
마감 07 11월 6:00AM
0.3113
0.0163
(5.53%)
시간외 거래: 9:57AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.3113
매수가
0.3227
매도가
0.34
거래량
656,092
0.2656 일간 변동폭 0.32
0.271701 52주 범위 2.655
market_cap
전일 종가
0.2825
개장가
0.28
최근 거래 시간
100
@
0.3113
(formt)
마지막 거래 시간
재정 규모
US$ 184,729
VWAP
0.28156
평균 볼륨(3m)
127,252
발행 주식
75,490,489
배당수익률
-
주가수익률
-9.98
주당순이익(EPS)
-1.1
매출
324.24M
순이익
-83.07M

Oncology Institute Inc 정보

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counsel... The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. 더 보기

섹터
Offices Of Medical Doctors
산업
Blank Checks
본부
Wilmington, Delaware, USA
설립됨
2021
Oncology Institute Inc is listed in the Offices Of Medical Doctors sector of the 나스닥 with ticker TOI. The last closing price for Oncology Institute was US$0.28. Over the last year, Oncology Institute shares have traded in a share price range of US$ 0.271701 to US$ 2.655.

Oncology Institute currently has 75,490,489 shares in issue. The market capitalisation of Oncology Institute is US$21.33 million. Oncology Institute has a price to earnings ratio (PE ratio) of -9.98.

TOI 최신 뉴스

The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that...

The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence

CERRITOS, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, has joined Lantern’s leading...

The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

CERRITOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) shared its partnership with the American Journal of Managed Care® (AJMC...

The Oncology Institute of Hope & Innovation Launches Oregon Market

CERRITOS, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, is proud to announce its expansion...

The Oncology Institute Announces CFO Transition

CERRITOS, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), today announced that Chief Financial Officer, Mihir Shah, will...

The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

CERRITOS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that...

The Oncology Institute to Participate at Upcoming Investor Conferences

CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0007-0.2243589743590.3120.39990.271701994820.2967167CS
4-0.0127-3.919753086420.3240.39990.271701791030.32506698CS
12-0.2062-39.8454106280.51750.51750.2717011272520.34599134CS
26-0.7587-70.90654205611.071.090.2717011469280.48010385CS
52-1.6887-84.43522.6550.2717011773361.24459466CS
156-9.5487-96.84279918869.8612.660.2717012230491.94758136CS
260-9.5487-96.84279918869.8612.660.2717012230491.94758136CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CONLGraniteShares ETF Trust GraniteShares
US$ 43.12
(61.62%)
25.09M
ARBBARB IOT Group Ltd
US$ 0.802709
(42.20%)
227.42M
ELWSEarlyworks Co Ltd
US$ 6.00
(41.18%)
6.04M
CTKBCytek Biosciences Inc
US$ 7.40
(36.03%)
4.19M
TMCITreace Medical Concepts Inc
US$ 7.78
(35.07%)
3.15M
BNOXBionomics Ltd
US$ 0.2839
(-42.41%)
17.56M
VSTEVast Renewable Ltd
US$ 3.09
(-42.35%)
2.65M
ZCARZoomcar Holdings Inc
US$ 7.6899
(-41.74%)
1.33M
ZVSAZyVersa Therapeutics Inc
US$ 1.5242
(-39.99%)
2.07M
TNGXTango Therapeutics Inc
US$ 3.22
(-37.84%)
14.86M
ELABElevai Labs Inc
US$ 0.0173
(-19.16%)
303.44M
NVDANVIDIA Corporation
US$ 145.61
(4.07%)
232.47M
ARBBARB IOT Group Ltd
US$ 0.802709
(42.20%)
224.6M
SQQQProShares UltraPro Short QQQ
US$ 6.6503
(-8.02%)
214.38M
DJTTrump Media and Technology Group Corporation
US$ 35.955
(5.94%)
171.54M

TOI Discussion

게시물 보기
Monksdream Monksdream 3 월 전
TOI
New 52 week low
👍️0
boston127 boston127 11 월 전
Thanks. I like it.

I may approach them about reselling my company's product.
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
MREO MY FAV BIO
👍️0
boston127 boston127 1 년 전
I did. Where do you recommend next?

Is this going to be a better play soon? I am in heavy, and in the red, with LGHL. would appreciate a quick look and feedback on that board, not here. TOI has so many good things going for it - owned by institutions - it is going to be hard for me not to eventually get in here.
👍️0
boywonder1 boywonder1 1 년 전
The chart has contradictions like yourself and you're posting history ‼️‼️2😂
👍️ 1 💯 1
TrendTrade2016 TrendTrade2016 1 년 전
Glad you listened
👍️0
boston127 boston127 1 년 전
You were correct. Took a major haircut.

Glad I did not jump in. Thanks. What do you like?
👍️0
boston127 boston127 1 년 전
The Warrants do not expire

until November, 2026. I may start adding them. I can get 10 Ws for every 1 Common.
👍️0
boston127 boston127 1 년 전
What important indicators?

TOI appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
As of 3:00 PM ET Friday, 11/03/2023
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
important indicators going down as stock is going up...red flag!!!!
👍️0
boston127 boston127 1 년 전
Can you explain?

Do you know anything about the warrants? Strike price, expiration date, etc.
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
CHART HAS SOME CONTRADICTIONS
👍️0
boston127 boston127 1 년 전
It sure is acting perky.

Nice move AH and Premarket. I'm going to jump in today if the move north continues.
👍️0
boston127 boston127 1 년 전
Common goes down.

Warrants go up on very light volume. Hard to figure.
👍️0
hedge_fun hedge_fun 1 년 전
She was under 40 cents in mid June……

I would say she’s is already flying.

Been my best play this year.
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TOI...READY TO FLY
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TOI...READY TO FLY
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
MONSTER IN DA MAKING
👍️0
hedge_fun hedge_fun 1 년 전
It’s tripled since mid-June…..
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
MONSTER PLAY HERE....
👍️0
TrendTrade2016 TrendTrade2016 1 년 전
TOI BEAUTY BOTTOM HERE ...AI CANCER PLAY
👍️0
hedge_fun hedge_fun 1 년 전
Company repurchasing more shares. Nice…..
👍️0
hedge_fun hedge_fun 1 년 전
August starting out like July…….
👍️0
hedge_fun hedge_fun 1 년 전
On watch. Thx
👍️0
CaptPete1776 CaptPete1776 1 년 전
Keep eye in $Getr over .55. That’s the breakout spot could explode over .70. I’ve been swinging this also.
👍️0
CaptPete1776 CaptPete1776 1 년 전
I have some left yes just don’t want to get to greedy
👍️0
hedge_fun hedge_fun 1 년 전
I hope you’re still holding some. I’m enjoying the ride.
👍️0
CaptPete1776 CaptPete1776 1 년 전
Looks great. I sold some here .89
👍️0
hedge_fun hedge_fun 1 년 전
I don’t want July to end!!!
👍️0
CaptPete1776 CaptPete1776 1 년 전
Holding in today's nasdaq slide and up on the day. .90 is coming next
👍️0
CaptPete1776 CaptPete1776 1 년 전
Yes definitely
👍️0
hedge_fun hedge_fun 1 년 전
Been a nice move the past 2 weeks……
👍️0
hedge_fun hedge_fun 1 년 전
The low volume dips with 100 share trades……

are fishy.

Maybe this proves to be support.

Long term hold for me.
👍️0
CaptPete1776 CaptPete1776 1 년 전
Let’s get more good new out. It’s been holding strong since the last news about stock repurchase plan.
👍️0
hedge_fun hedge_fun 1 년 전
On June 14, 2023, the Board of Directors of The Oncology Institute, Inc. (the “Company”) approved a share repurchase program with authorization to purchase up to 5 million shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The Company may repurchase shares from time to time through one or more securities broker-dealers, in open market purchases and negotiated purchases, in each case at price per share not to exceed $0.75. Shares repurchased by the Company pursuant to the share repurchase program shall be returned to the status of authorized but unissued shares of Common Stock.

In connection with the foregoing, on June 14, 2023, the Company entered into a limited consent (the “Limited Consent”), dated as of June 14, 2023, to that certain Facility Agreement, dated as of August 9, 2022 (the “Facility Agreement”), by and among the Company, as borrower, certain of the Company’s subsidiaries from time to time party thereto as guarantors and Deerfield Partners, L.P., as agent for itself and the lenders (collectively, “Deerfield”). The Limited Consent permits the repurchase by the Company on or prior to June 16, 2023, of up to 5,000,000 shares of the Company’s Common Stock in one or more open market or negotiated purchases, in each case at price per share not to exceed $0.75. The actual timing and amount of repurchases are subject to business and market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors. The Limited Consent does not obligate the Company to repurchase any amount of shares, and there can be no assurance that any shares will be repurchased. The Limited Consent also grants a one-time waiver under the Facility Agreement of certain delivery of any notice requirements.

The foregoing description of the Limited Consent does not purport to be complete and is qualified in its entirety by reference to the full text of the Limited Consent, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
👍️0

최근 히스토리

Delayed Upgrade Clock